🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

9717+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 9717 recruiting trials

Phase 3RecruitingNCT06451757

KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

🏥 Khondrion BV📍 10 sites📅 Started Feb 2026View details ↗
Enrolling by InvitationNCT07413224

Qualitative Effects of AEF0217 in Down Syndrome People

👨‍⚕️ Pier Vincenzo Piazza, MD, PhD, Aelis Farma📍 1 site📅 Started Feb 2026View details ↗
Phase 3RecruitingNCT07390123

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

🏥 Haisco Pharmaceutical Group Co., Ltd.📍 1 site📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07419373

ARN-75039 Lassa Fever Treatment in West Africa

👨‍⚕️ Ken McCormack, PhD, Arisan Therapeutics, Inc.📍 4 sites📅 Started Feb 2026View details ↗
Phase 3RecruitingNCT07407803

Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas

🏥 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.📍 29 sites📅 Started Feb 2026View details ↗
Phase 1RecruitingNCT07166419

Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia

👨‍⚕️ Sumithira Vasu, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Feb 2026View details ↗
Phase 4RecruitingNCT07280468

Endotype DIrected Treatment for OSA in Down Syndrome

👨‍⚕️ Daniel Combs, MD, University of Arizona📍 4 sites📅 Started Feb 2026View details ↗
NARecruitingNCT07413796

Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures

👨‍⚕️ Michał Senger, M.D., Department of Neurosurgery, Medical University of Warsaw, Warsaw, Poland📍 1 site📅 Started Feb 2026View details ↗
Phase 3RecruitingNCT06963216

A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis

👨‍⚕️ Mirella Calcinai, MD, Medical Director, Clinical Development📍 3 sites📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07338344

Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT Patients

🏥 Rongrong Liu📍 8 sites📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07403136

Vebrekotuzumab ± Anti-PD-1 in Pretreated Advanced ESCC

🏥 Fudan University📍 1 site📅 Started Feb 2026View details ↗
Phase 1RecruitingNCT07270978

Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS

👨‍⚕️ Daniel Reed, MD, Assistant Professor📍 1 site📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07432295

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

🏥 I-Mab Biopharma US Limited📍 3 sites📅 Started Feb 2026View details ↗
NARecruitingNCT07405125

Safety of Robotic Surgery for GISTs at Special Anatomic Sites

🏥 The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Feb 2026View details ↗
NARecruitingNCT07365566

Pain Assessment in Patients With Idiopathic REM Sleep Behaviour Disorder

🏥 University Hospital, Toulouse📍 1 site📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07222579

Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)

👨‍⚕️ Ashkan Emadi, MD, WVU Cancer Institute📍 1 site📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07356245

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

👨‍⚕️ Jonathan Brammer, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Feb 2026View details ↗
Phase 1RecruitingNCT07102394

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

👨‍⚕️ Carlos Romo, MD, Johns Hopkins University📍 1 site📅 Started Feb 2026View details ↗
Phase 1, PHASE2RecruitingNCT07182227

PS-002 for the Treatment of IgA Nephropathy in Adults

🏥 Purespring Therapeutics Limited📍 11 sites📅 Started Feb 2026View details ↗
NARecruitingNCT07461090

Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost Analysis

🏥 Menoufia University📍 1 site📅 Started Feb 2026View details ↗
← PreviousPage 17 of 486Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →